JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information: Press Releases

JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information: Press Releases

The Japanese Foundation for Cancer Research (JFCR), NEC Corporation (NEC), and Taiho Pharmaceutical Co., Ltd. (Taiho) have signed a three-party joint research (Joint Research) agreement aimed at developing new cancer vaccines…

Continue Reading